SUBOPTIMAL INHIBITION OF PLATELET CYCLOOXYGENASE-1 BY ASPIRIN IN METABOLIC SYNDROME

Interindividual variation in the ability of aspirin to inhibit platelet cyclooxygenase-1 (COX-1) could account for some on-treatment cardiovascular events. Here, we sought to determine whether there are clinical phenotypes that are associated with a suboptimal pharmacological effect of aspirin. In a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Smith, James P., Haddad, Elias V., Taylor, Mary B., Oram, Denise, Blakemore, Dana, Chen, Qingxia, Boutaud, Olivier, Oates, John A.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3418792/
https://ncbi.nlm.nih.gov/pubmed/22311905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.111.181404
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars